People

Aimee Moore Named Permanent CFO at VitalPath

The former interim CFO has more than 29 years of progressive accounting and financial leadership experience.

By: Michael Barbella

Managing Editor

Aimee Moore. Headshot: VitalPath.

VitalPath’s interim chief financial officer (CFO) now has the job permanently.

Aimee Moore joined the complex catheter and precision laser component provider last year and quickly made a significant impact by strengthening financial strategy and supporting the company’s long-term growth initiatives.

“We are thrilled to welcome Aimee as our permanent CFO,” VitalPath CEO Bill Ellerkamp said. “She’s a results-driven leader who isn’t afraid to roll up her sleeves. Her hands-on approach and ability to elevate our financial strategy have already made her an invaluable asset. I’m excited to continue working alongside her as we accelerate VitalPath’s growth trajectory.”

With more than 29 years of progressive accounting and financial leadership experience, Moore has built a career as a trusted business partner to executive teams delivering accurate, timely financial insights that drive informed decision-making. Her previous roles include leadership positions at Alpine Software Group, Spartronics LLC, Cliq Studios, Cogentix Medical, and Salo LLC.

“I’m honored to officially step into the CFO role at VitalPath,” Moore stated. “There’s a deep sense of purpose in being part of a company so committed to improving patients’ lives. I look forward to partnering with Bill and the executive leadership team to drive financial excellence, enhance operational efficiency, and continue expanding our impact in the market.”

Moore is a CPA (inactive) and earned a bachelor’s degree in accounting from the Carlson School of Management at the University of Minnesota, as well as a bachelor’s degree in Spanish and government from the University of Virginia.

In partnership with customers, VitalPath delivers high-quality complex catheter solutions. The VitalPath team specializes in meeting customers’ most challenging complex catheter design and manufacturing requirements, built on a suite of precision component manufacturing capabilities. The company is ISO 13485:2016 certified with a U.S. Food and Drug Administration-registered site, including ISO 7 & 8 cleanrooms.

Inverness Graham is a Philadelphia-based buyout firm focused on acquiring high-growth companies where technology is transforming traditional industry. The firm’s flagship strategy focuses on businesses in healthcare, tech-enabled services/software, and advanced manufacturing. The firm’s Green Light strategy targets tech-enabled businesses where environmental sustainability is a key growth driver. Inverness Graham executes a differentiated, repeatable model for value creation through its proprietary Strategic Platform Build approach. Founded by senior executives of the Graham Group, the firm builds upon a 60-year legacy of operational excellence, bringing substantial value creation resources and an innovative mindset to support its portfolio company partners.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters